Search - tctmd.com

Displaying 1 - 20 of 120

Sort: Relevancy | Date

News Daily News

AHA Statement Addresses ACS Management Gap in Younger Women

L.A. McKeown

February 09, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

Caitlin E. Cox

December 04, 2025

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Todd Neale

November 08, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

News Conference News ACC 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

Yael L. Maxwell

March 29, 2025

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

Advertisement

AHA Statement Addresses ACS Management Gap in Younger Women

TCTMD’s Top 10 Most Popular Stories for December 2025

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Frailty Extra Risky in Young Patients With Acute MI

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

Risk Factors Present in Nearly All Patients Who Develop CVD

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Evolocumab Gains Expanded Indication for Primary Prevention

WARRIOR: No Clear Answers on How to Best Treat INOCA

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Telemedicine Strategy After MI Scores a Win in TELE-ACS

February 2024 Dispatch for the CV Team

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content